Skip to main content

Traverse Biotech

  • | Biotech or pharma, therapeutic R&D

Traverse Biotech, INC (Traverse) is a US immunotherapy company that develops first-in-class therapies to rearm the immune system, making it part of the cure. We are raising capital to support the clinical entrance of a novel T-cell engaging (TCE) bispecific antibody, TB-Bs1, that targets ROR2 in solid tumor cancers.

Address

New York
New York
United States
Visit website

Contact Exhibitor


Loading
View all Exhibitors
Testimonials

Double Helix


 

Supporting Bank Sponsor


 

Premier Sponsors

Conference Sponsors